Insights on Clinical Trials
-
EHR-To-EDC: The Way Of The Future Or A Pipe Dream?
3/14/2025
Learn more about the best practices for EHR-to-EDC integration and the immense potential of the type of transfer as clinical trials move toward greater efficiency.
-
Why Academic Researchers Rely On OpenClinica Recruit
3/14/2025
OpenClinica Recruit offers a flexible, user-friendly participant management system with real-time tracking and transparent pricing.
-
Recruiting & Retaining More Patients Per Site:
3/14/2025
Through Home Trial Support (HTS) services, MRN is able to enhance the accessibility of clinical trials while reducing the emotional toll on their patients suffering from loss of mobility.
-
Collaboration Leads To CGT Progress At Astellas' West Coast Innovation Center
3/13/2025
Yoshi Shitaka, outgoing CSO and Richard Wilson, SVP, Primary Focus Lead (Genetic Regulation) at Astellas share how the company's West Coast Innovation Center serves as a central hub for AI, digital transformation, and more.
-
Multi-Regional Clinical Trials: The Latest Guidance From FDA
3/12/2025
Conducting multi-regional clinical trials (MRCTs) is essential for accelerating oncology drug development and ensuring broader patient access. However, differences across regions can impact findings.
-
The Strategic Backbone Of Marketing Application Success
3/12/2025
Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.
-
Taking A Statistics-Driven Approach To Clinical Trial Planning
3/12/2025
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
-
Navigating Patient Access Challenges In Commercializing Your CGT Product
3/10/2025
Learn how to effectively break down barriers to patient access in cell and gene therapy by enhancing provider education, streamlining coordination, and expanding patient support.
-
Challenges In Manufacturing TIL For Clinical Trials
3/6/2025
Tumor-infiltrating lymphocyte cell therapy shows promise for treating solid tumors, but its complex manufacturing profile brings a unique set of issues. Here are some things to watch out for.
-
Hepatitis B - Global Clinical Trial Landscape
3/6/2025
As Hepatitis B virus (HBV) clinical trials advance, refining therapeutic endpoints and integrating novel treatment strategies are essential to transforming Hepatitis B management.